NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-DA-17-018 from the NIH Guide for Grants and Contracts
Notice NOT-DA-17-017 from the NIH Guide for Grants and Contracts
Notice NOT-DA-17-019 from the NIH Guide for Grants and Contracts
Notice NOT-CA-17-048 from the NIH Guide for Grants and Contracts
Notice NOT-OD-17-055 from the NIH Guide for Grants and Contracts
Notice NOT-OD-17-054 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-17-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for the George M. OBrien Kidney Research Centers to support both basic and clinical research on kidney disease. The goal of the O'Brien Kidney Research Center program is to make state-of-the art technologies and resources readily accessible to a broad spectrum of investigators pursuing studies in relevant topic areas. The emphases for this program are fourfold: (1) to attract new scientific expertise to and develop new tools for the study of human kidney physiology and disorders in humans and in animal and other models; (2) to encourage multidisciplinary research in these areas; 3) To explore new areas with translational potential; and 4) to generate Developmental Research (DR)/Pilot and Feasibility (P and F) studies which could lead to new and innovative approaches to study kidney disease. Information about the current George M. O'Brien Kidney Research Core Centers may be found at the following URL: https://www.niddk.nih.gov/research-funding/process/apply/about-funding-mechanisms/p30/pages/p30.aspx/.
Funding Opportunity RFA-AI-17-010 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications to support innovative preclinical research to identify Mycobacterium tuberculosis (Mtb)-mediated changes in key immune cell regulatory pathways in the context of HIV infection and evaluate strategies to reverse these changes to treat TB and TB/HIV infection, limit long-term disease associated tissue damage, and/or potentiate vaccine effectiveness.
Notice NOT-TR-17-015 from the NIH Guide for Grants and Contracts
Notice NOT-DA-17-015 from the NIH Guide for Grants and Contracts
Notice NOT-DA-17-016 from the NIH Guide for Grants and Contracts
Notice NOT-CA-17-046 from the NIH Guide for Grants and Contracts
Notice NOT-CA-17-047 from the NIH Guide for Grants and Contracts
Notice NOT-AI-17-023 from the NIH Guide for Grants and Contracts
Notice NOT-HL-17-507 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NR-17-001 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue support for the research and resource activities of the Palliative Care Research Cooperative (PCRC); and facilitate cutting edge end-of-life and palliative care (EOLPC) research studies that need to be conducted with nationally representative samples and multiple sites.
Notice NOT-HD-17-010 from the NIH Guide for Grants and Contracts
Notice NOT-HD-17-009 from the NIH Guide for Grants and Contracts
Notice NOT-RM-17-016 from the NIH Guide for Grants and Contracts
Notice NOT-DA-17-014 from the NIH Guide for Grants and Contracts